New hypoglycemic agents that inhibit renal glucose reabsorption are valuable in the constant search for therapeutic tools that achieve glycemic control in patients with diabetes mellitus. In this Perspectives article, Amanda Mather and Carol Pollock discuss novel agents that inhibit the principal glucose transporter in the kidney, which can be added to the armamentarium against hyperglycemia.
- Amanda Mather
- Carol Pollock